Sigma Planning Corp Regenxbio Inc. Transaction History

Sigma Planning Corp

$3.02 Billion
Q1 2025

A detailed history of Sigma Planning Corp transactions in Regenxbio Inc. stock. As of the latest transaction made, Sigma Planning Corp holds 35,860 shares of RGNX stock, worth $321,305. This represents 0.01% of its overall portfolio holdings.

Number of Shares

35,860

Previous 37,310 3.89%

Holding current value

$321,305

Previous $288,000 11.11%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$5.92 - $8.7 $8,584 - $12,614	-1,450 Reduced 3.89%	35,860 $256,000
Q4 2024 Feb 03, 2025	SELL	$7.23 - $11.56 $6,507 - $10,404	-900 Reduced 2.36%	37,310 $288,000
Q3 2024 Nov 01, 2024	BUY	$10.49 - $14.39 $59,803 - $82,037	5,701 Added 17.54%	38,210 $400,000
Q2 2024 Aug 05, 2024	BUY	$11.51 - $21.53 $56,790 - $106,229	4,934 Added 17.89%	32,509 $380,000
Q1 2024 May 01, 2024	BUY	$12.17 - $24.61 $184,314 - $372,718	15,145 Added 121.84%	27,575 $581,000
Q4 2023 Feb 01, 2024	SELL	$12.89 - $20.82 $283,721 - $458,269	-22,011 Reduced 63.91%	12,430 $223,000
Q3 2023 Nov 06, 2023	SELL	$16.46 - $19.99 $246 - $299	-15 Reduced 0.04%	34,441 $566,000
Q2 2023 Aug 01, 2023	BUY	$17.23 - $21.71 $79,430 - $100,083	4,610 Added 15.45%	34,456 $688,000
Q1 2023 May 05, 2023	BUY	$18.08 - $24.55 $129,723 - $176,146	7,175 Added 31.65%	29,846 $564,000
Q4 2022 Jan 24, 2023	SELL	$20.4 - $24.73 $2,182 - $2,646	-107 Reduced 0.47%	22,671 $0
Q3 2022 Nov 10, 2022	SELL	$22.29 - $35.04 $46,140 - $72,532	-2,070 Reduced 8.33%	22,778 $602,000
Q2 2022 Aug 11, 2022	BUY	$19.35 - $35.04 $3,424 - $6,202	177 Added 0.72%	24,848 $614,000
Q1 2022 Apr 20, 2022	SELL	$24.62 - $34.31 $615 - $857	-25 Reduced 0.1%	24,671 $819,000
Q4 2021 Feb 02, 2022	SELL	$30.19 - $40.28 $3,532 - $4,712	-117 Reduced 0.47%	24,696 $808,000
Q3 2021 Oct 28, 2021	BUY	$29.09 - $45.68 $26,355 - $41,386	906 Added 3.79%	24,813 $1.04 Million
Q2 2021 Aug 13, 2021	BUY	$32.46 - $40.48 $4,609 - $5,748	142 Added 0.6%	23,907 $929,000
Q1 2021 May 06, 2021	BUY	$33.61 - $49.95 $798,741 - $1.19 Million	23,765 New	23,765 $811,000
Q3 2018 Nov 07, 2018	SELL	$65.0 - $82.15 $206,700 - $261,237	-3,180 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$27.2 - $74.35 $86,496 - $236,432	3,180 New	3,180 $228,000

Others Institutions Holding RGNX

# of Institutions

182

Shares Held

45.5M

Call Options Held

64.9K

Put Options Held

103K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $387M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account

Sigma Planning Corp Regenxbio Inc. Transaction History